Update: Hypogonadotropic Hypogonadism in Type 2 Diabetes and Obesity
Open accessThe DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Abstract
Studies over the last few years have clearly established that at least 25% of men with type 2 diabetes have subnormal free testosterone concentrations in association with inappropriately low LH and FSH concentrations. Another 4% have subnormal testosterone concentrations with elevated LH and FSH concentrations. The Endocrine Society, therefore, now recommends the measurement of testosterone in patients with type 2 diabetes on a routine basis. The subnormal testosterone concentrations are not related to glycosylated hemoglobin or duration of diabetes, but are associated with obesity, very high C-reactive protein concentrations, and mild anemia. In addition, subnormal testosterone concentrations in these men are associated with a two to three times elevated risk of cardiovascular events and death in two early studies. Short-term studies of testosterone therapy in hypogonadal men with type 2 diabetes have demonstrated an increase in insulin sensitivity and a decrease in waist circumference. However, the data on the effect of testosterone replacement on glycemic control and cardiovascular risk factors such as cholesterol and C-reactive protein concentrations are inconsistent. As far as sexual function is concerned, testosterone treatment increases libido but does not improve erectile dysfunction and thus, phosphodiesterase inhibitors may be required. Trials of a longer duration are clearly required to definitively establish the benefits and risks of testosterone replacement in patients with type 2 diabetes and low testosterone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Obese subjects often have reduced gonadotropin concentrations indicating that the primary effect is mediated at the hypothalamus-pituitary level rather than at the testicular level [38].”
From Causal relationship between obesity and serum testosterone status in men: A bi-directional mendelian randomization analysis (2017) · cites this paper as [38]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The increased amount of estrogen levels might, in turn, play a negative feedback on both the hypothalamus and the pituitary, leading to decreased LH secretion (22,55).”
From Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis (2013) · cites this paper as [55]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Thus high BMI seems to repress serum T mainly via central inhibitory effects on gonadotropin secretion [38, 41].”
From Causal relationship between obesity and serum testosterone status in men: A bi-directional mendelian randomization analysis (2017) · cites this paper as [38]
The cited source says what the claim attributes to it.
In the citing paper
“Based on these and other studies (53,54), obesity-related male hypogonadism is now considered as a form of hypogonadotropic hypogonadism (see for a review, references (55,56)).”
From Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis (2013) · cites this paper as [55]
The cited source says what the claim attributes to it.
In the citing paper
“Accordingly, patients with T2DM and insulin resistance show a higher prevalence of hypogonadotropic hypogonadism (54,55,60)”
From Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis (2013) · cites this paper as [55]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of Brain Insulin Receptor in Control of Body Weight and Reproduction
Brüning, J. C., Gautam, D., Burks, D. J., Gillette, J., Schubert, M., Orban, P. C., Klein, R., Krone, W., Müller-Wieland, D., & Kahn, C. R. (2000) · Science · doi:10.1126/science.289.5487.2122 · Cited by 2,235
Inflammation: the link between insulin resistance, obesity and diabetes
Dandona, P. (2004) · Trends in Immunology · doi:10.1016/j.it.2003.10.013 · Cited by 2,170
Self-citationAdverse Events Associated with Testosterone Administration
Basaria, S., Coviello, A. D., Travison, T. G., Storer, T. W., Farwell, W. R., Jette, A. M., Eder, R., Tennstedt, S., Ulloor, J., Zhang, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000485 · Cited by 1,494
Bhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Montori, V. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2847 · Cited by 965
Khosla, S., Amin, S., & Orwoll, E. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0002 · Cited by 930
Laaksonen, D. E., Niskanen, L., Punnonen, K., Nyyssönen, K., Tuomainen, T.-P., Valkonen, V.-P., Salonen, R., & Salonen, J. T. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1036 · Cited by 920
Low Serum Testosterone and Mortality in Older Men
Laughlin, G. A., Barrett-Connor, E., & Bergstrom, J. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1792 · Cited by 798
Kapoor, D., Goodwin, E., Channer, K. S., & Jones, T. H. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02166 · Cited by 791
Khaw, K.-T., Dowsett, M., Folkerd, E., Bingham, S., Wareham, N., Luben, R., Welch, A., & Day, N. (2007) · Circulation · doi:10.1161/circulationaha.107.719005 · Cited by 743
Sex hormone-binding globulin and risk of type 2 diabetes in women and men
Ding, E. L., Song, Y., Manson, J. E., Hunter, D. J., Lee, C. C., Rifai, N., Buring, J. E., Gaziano, J. M., & Liu, S. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0804381 · Cited by 726
Cited by
Items 201–300 of 313
Stone, N. N., Miner, M. M., Poage, W. L., Patel, A., & Crawford, E. D. (2014) · Journal of Men s Health · doi:10.1089/jomh.2013.0027 · Cited by 3
Health Consequences–Obesity Associated Comorbidities
Emmanuel, J. J., & Coppack, S. W. (2015) · Springer eBooks · doi:10.1007/978-3-319-04343-2_4 · Cited by 4
Kanabur, P., Brunner, R. L., Khera, D., Flores, H. A., & Khera, M. (2022) · Androgens Clinical Research and Therapeutics · doi:10.1089/andro.2021.0025 · Cited by 4
Prevalence of Hypogonadism in Low-Risk Prostate Cancer Survivors.
Agrawal, L., Arceo-Mendoza, R. M., Barnosky, A., Bresler, L., Chiha, M., Silva, A., & Wilczynski, C. (2016) · Europe PMC (PubMed Central) · Cited by 3
Assessment of the Obese Patient
Bessesen, D. H. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1203-2_12 · Cited by 3
“Obese men are more likely than their lean counterparts to experience decreased libido and have low testosterone levels [ 93 ].”
BackgroundValencia, W. M., & Florez, H. J. (2016) · Springer eBooks · doi:10.1007/978-3-319-31831-8_22 · Cited by 3
Agarwal, A. K., & Dutta, S. (2020) · Springer eBooks · doi:10.1007/978-3-030-32300-4_39 · Cited by 3
Kharazi, U., Keyhanmanesh, ., Hamidian, G., Ghaderpour, S., & Ghiasi, R. (2021) · PubMed Central · doi:10.22038/ijbms.2021.58740.13048 · Cited by 5
Wh, K., Sukor, N., & Kamaruddin, N. A. (2025) · Journal of Diabetes Investigation · doi:10.1111/jdi.70127 · Cited by 3
“52,53 One plausible explanation is the environmental in fl uence of endocrine-disruptor compounds (EDC) affecting our participants.”
The link between diabetes and male infertility: mechanisms and implications
Haffez, H., Mosaad, M., Rezk, A. Y., Sayed, A. I., & Hassan, Z. A. (2026) · Scientific Reports · doi:10.1038/s41598-026-63095-w · Cited by 2
“In our cohort, the diabetic groups showed alterations in gonadotropin profiles, particularly FSH and LH changes, supporting the presence of endocrine dysregulation despite the absence of a statistically significant testosterone difference among the four subgroups 28,29 .”
Testosterone Decreases Erythropoietin Stimulating Agent Use in Men on Hemodialysis
Dhindsa, S., Nargunan, V., Reddy, A., Clubb, C., Haider, A., Cheng, F., Prasad, V. H., & Dandona, P. (2020) · Androgens Clinical Research and Therapeutics · doi:10.1089/andro.2020.0003 · Cited by 3
Self-citationHohl, A., & Ronsoni, M. F. (2022) · Springer eBooks · doi:10.1007/978-3-030-90684-9_14 · Cited by 6
Mei, Y., Lyu, Y., Le, J., Li, D., Liu, H., Zhao, Z., & Li, Y. (2022) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3564 · Cited by 2
Anastassakis, K. (2022) · Springer eBooks · doi:10.1007/978-3-031-08057-9_26 · Cited by 5
Elhaliem, H. A., & Zwain, B. (2023) · Egyptian Journal of Nutrition and Health · doi:10.21608/ejnh.2023.283075 · Cited by 2
Alaamri, S., Serafi, A. S., Hussain, Z., Bafail, S. K., Bafail, M. A., Demirkhanyan, L. H., Gondi, C. S., & Sohail, S. (2025) · Pathophysiology · doi:10.3390/pathophysiology32010007 · Cited by 4
“A high increase in BW is accompanied by elevated levels of aromatase from fat that decrease the hypothalamic–pituitary–testis pathway and hence cause a decrease in ST production by Leydig cells in the testes [63].”
Association of night‐time sleep and day napping with the prevalence of MOSH in young obese men
Chen, Y., Zhang, L., Zhao, S., Yuan, L., Shi, J., Zhang, Y., Wang, J., Gu, W., Wang, W., & Hong, J. (2021) · Andrology · doi:10.1111/andr.13074 · Cited by 3
Obesity-related metabolic and reproductive dysfunction: variations between the sexes
Dimitriadis, G. K., & Barber, T. M. (2016) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2016.1220301 · Cited by 3
“The relationship between adiposity, estradiol, and testosterone in MOSH is even more complex though, because with increasing adiposity there is a point at which no further increase in serum estradiol occurs, primarily due to limited testosterone reserve [35,36].”
BackgroundDiabetes mellitus: historical background, global aspects, and impact in Suriname
Toelsie, J. R., Bipat, R., Algoe, M., & Mans, D. R. A. (2013) · Academic Journal of Suriname · Cited by 2
Maiorino, M. I., Bellastella, G., & Esposito, K. (2018) · Endocrinology · doi:10.1007/978-3-319-27316-7_16-1 · Cited by 2
Zhao, P. T., Su, D., & Seftel, A. D. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4773-3_11 · Cited by 2
Almihy, N., Eissa, E. A., Amer, E., & Elassal, M. (2015) · Benha Medical Journal · doi:10.4103/1110-208x.170556 · Cited by 4
Pituitary Evaluation in Patients with Low Prostate-Specific Antigen
Drincic, A., Nguyen, A.-T., Singh, S., Zena, M., Walters, R. W., Friedman, K., & Anderson, R. J. (2018) · Endocrine Practice · doi:10.4158/ep-2018-0204 · Cited by 2
Winters, S. J. (2022) · Springer eBooks · doi:10.1007/978-3-030-84367-0_30 · Cited by 2
López, G. P., Cebrián, S. B., Fernández, L. G., & Albarrán, O. G. (2024) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2024.09.003 · Cited by 2
Zhao, Y., Cao, C., Hua, R., Tan, X., Chu, Y., He, M., Yao, X., Xu, B., Shen, Q., Fu, X., et al. (2026) · Journal of Endocrinological Investigation · doi:10.1007/s40618-026-02922-3 · Cited by 1
New Insight Into Male Infertility: Deviation From Basic Tenets of Life
Nasr‐Esfahani, M. H., Naderi, N., Tavalaee, M., & Razi, M. (2026) · Oxidative Medicine and Cellular Longevity · doi:10.1155/omcl/4433444 · Cited by 1
“The study also highlighted the association between type 2 diabetes, obesity, and hypogonadotropic hypogonadism, suggesting a shared pathophysiological basis [183].”
Miulescu, R. D., Dănoiu, S., Margina, D. M., Paun, S. C., & Poiană, C. (2012) · Romanian Journal of Diabetes Nutrition and Metabolic Diseases · doi:10.2478/v10255-012-0046-9 · Cited by 1
“Trials of a longer duration are clearly required to definitively establish the benefits and risks of testosterone replacement in patients with type 2 diabetes and low testosterone" [14].”
BackgroundDehydroepiandrosterone in the type 1 diabetes mellitus
Dušková, M., Hruškovičová, H., Hill, M., & Stárka, L. (2012) · Endocrine Regulations · doi:10.4149/endo_2012_02_67 · Cited by 1
Reproductive Disorders and Obesity in Males and Females and Focus on the Polycystic Ovary Syndrome
Repaci, A., & Pasquali, R. (2015) · Springer eBooks · doi:10.1007/978-3-319-12125-3_40-1 · Cited by 2
Impact of Diabetes Mellitus and Obesity on Male Infertility in Iraqi patients
Zamil, G. O. Z. G. O. (2013) · IOSR Journal of Applied Chemistry · doi:10.9790/5736-0430913 · Cited by 1
“At least 25% of men with T2DM have evidence of secondary hypogonadism, and an additional 4% have primary hypogonadism [14].”
BackgroundKhan, S. H., Anwar, R., Amin, Z., Fazal, N., Gilani, A. A. S., & Tariq, M. (2019) · Journal of College of Physicians And Surgeons Pakistan · doi:10.29271/jcpsp.2019.12.1153
Li, F., Qiu, X., Yao, H., & Chang, D. (2020) · Medicine · doi:10.1097/md.0000000000020665 · Cited by 1
Maiorino, M. I., Bellastella, G., & Esposito, K. (2018) · Endocrinology · doi:10.1007/978-3-319-44433-8_16 · Cited by 1
Effect of Diabetes Mellitus on Hypogonadism in Chronic Renal Failure
Karataş, S., & Köse, Ş. (2022) · Medical Laboratory Technology Journal · doi:10.31964/mltj.v8i1.467 · Cited by 1
Male Infertility in Diabetes Mellitus: An Insight into the Pathophysiology
Kamrul-Hasan, A. B. M., Aalpona, F. T. Z., Bhat, S., Mondal, S., Dasgupta, A., & Selim, S. (2023) · Bangladesh Journal of Endocrinology and Metabolism · doi:10.4103/bjem.bjem_8_23 · Cited by 3
Udoh, E. A., Akaiso, O. E., & Ukpong, A. E. (2023) · SAS Journal of Medicine · doi:10.36347/sasjm.2023.v09i10.004 · Cited by 1
Navigating the Intersection of Glycemic Control and Fertility: A Network Perspective
Carlo, C. D., Cimini, C., Belda-Pérez, R., Valbonetti, L., Bernabò, N., & Barboni, B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25189967 · Cited by 2
“In men, lower testosterone levels induced by T2DM cause erectile dysfunction and decreased motility, quality, or concentration levels of spermatozoa [12].”
BackgroundIncidence, Temporal Trends, and Socioeconomic Aspects of Acquired Male Hypogonadism
Percik, R., Vered, S., & Liel, Y. (2025) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-2556-2844 · Cited by 2
“Hy-pogonadotropic hypogonadism is common among adult men with components of the “metabolic syndrome”, obesity, and diabetes [1, 2] and is associated with mental stress [3].”
Shazley, O., & Orr, C. (2025) · Cureus · doi:10.7759/cureus.91389 · Cited by 1
Shonibare, T., Rodriguez-Farradas, A., Ramasamy, M., & Rajeswaran, C. (2015) · Springer eBooks · doi:10.1007/978-1-4471-2789-5_23 · Cited by 1
MALE HYPERGLYCEMIC-INDUCED INFERTILITY: AN INTEGRATION OF SOME BIOCHEMICAL FACTORS
Opuene, E. (2014) · Cited by 1
Hypogonadism in Male Sexual Dysfunction
Stoian, D. L., Mozos, I. M., Craina, M. L., Paul, C., Velea, I. P., Schiller, A., & Crăciunescu, M. (2017) · InTech eBooks · doi:10.5772/intechopen.69107 · Cited by 2
Erectile dysfunction in type 2 diabetics: Does it need more attention?
Chakraborty, J., Chakraborty, S., & Chakraborty, R. (2018) · Journal of integrative nephrology and andrology · doi:10.4103/jina.jina_32_17 · Cited by 1
Age-Related Testosterone Deficiency Merits Treatment
Traish, A. M. (2021) · Androgens Clinical Research and Therapeutics · doi:10.1089/andro.2020.0019 · Cited by 4
Kisspeptin: From Bench to Bedside
Mills, E., Patel, B., & Dhillo, W. S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00021-9 · Cited by 1
Male Sexual and Reproductive Health
Tharakan, T., Minhas, S., & Jayasena, C. N. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00036-0 · Cited by 1
Severe obesity, hypogonadotropic hypogonadism and a WDR11 gene mutation
Lu, D., Yang, J., Zhang, J., & Guo, X. (2021) · QJM · doi:10.1093/qjmed/hcab279 · Cited by 2
Kutty, P. K., & Kutty, M. K. (2021) · Springer eBooks · doi:10.1007/978-981-33-6408-0_5 · Cited by 1
Maiorino, M. I., Bellastella, G., & Esposito, K. (2019) · Endocrinology · doi:10.1007/978-3-319-27316-7_16-3 · Cited by 1
Obesity-Associated Comorbidities: Health Consequences
Adebibe, M., & Coppack, S. W. (2023) · Springer eBooks · doi:10.1007/978-3-030-60596-4_4 · Cited by 1
Seftel, A. D. (2011) · The Journal of Urology · doi:10.1016/j.juro.2011.10.095 · Cited by 1
“Short-term studies of testosterone therapy in hypogonadal men with type 2 diabetes have demonstrated an increase in insulin sensitivity and a decrease in waist circumference.(1)”
BackgroundGlintborg, D., Christensen Louise, L., Kvorning, T., Larsen, R., Brixen, K., Hougaard David, M., Richelsen, B., Bruun Jens, M., & Andersen Marianne, S. (2013) · Endocrine Abstracts · doi:10.1530/endoabs.32.p638 · Cited by 1
Assessment of the Obese Patient
Bessesen, D. H. (2014) · Springer eBooks · doi:10.1007/978-1-4939-2311-3_12 · Cited by 1
Sweeting, A. (2022) · Wiley eBooks · doi:10.1002/9781119695257.ch12 · Cited by 3
Alaamri, S., Serafi, A. S., Hussain, Z., Bafail, S. K., Bafail, M. A., Demirkhanyan, L. H., Gondi, C. S., & Sohail, S. (2023) · Preprints.org · doi:10.20944/preprints202306.1479.v1 · Cited by 1
Association between androgen deficiency and metabolic syndrome in men with type 2 diabetes mellitus
Mohieldein, A., Alzohairy, M. A., & Hasan, M. (2014) · International Journal of Biomedical Research · doi:10.7439/ijbr.v5i3.535
Aftab, S. S. A., Kumar, S., & Barber, T. M. (2013) · Clinical Endocrinology · doi:10.1111/cen.12244
Perfil androgênico em pacientes obesos graves do sexo masculino submetidos à cirurgia bariátrica
Rosenblatt, A. (2012) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2012.tde-27022013-115309 · Cited by 1
Hipogonadismo asociado a diabetes mellitus 2 con obesidad.
Oloarte, R., & Carlos, J. (2015)
Low Testosterone and the Metabolic Syndrome
Winters, S. J. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2059-4_36
[Clinical and biochemical diagnosis of androgenic deficit in adult men].
Mas, M. (2013) · PubMed
Fertility and Testosterone Improvement in Male Patients After Bariatric Surgery
Luconi, M., Corona, G., Facchiano, E., Lucchese, M., & Maggi, M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800872-0.00010-x
Стан статевої функції у чоловіків, хворих на цукровий діабет 2-го типу
Luchytskyi, V. Y. (2016) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.4.68.2015.75018
Causas y consecuencias del hipogonadismo en varones con diabetes mellitus tipo 2
Ruiz, A. H. (2015) · Gredos (University of Salamanca) · doi:10.14201/gredos.128430
Non-menopausal endocrine and non-endocrine causes of flushing and sweating
Lal, V., Mamoojee, Y. H., & Quinton, R. (2017) · Post Reproductive Health · doi:10.1177/2053369117715371 · Cited by 1
“Obesity (in males, but not females) has been associated with down-regulation of the hypothalamo-pituitary gonadal axis resulting in secondary hypogonadism – sweating being a symptom thereof.(9) In addition, the state of pre-diabetes, impaired glucose tolerance, or even very early stage Type 2 diabetes is characterised…”
BackgroundGanie, M. A., Rahaman, S. H., & Raizada, N. (2017) · Springer eBooks · doi:10.1007/978-981-10-3695-8_23
Characterizing the Role of Insulin Signalling in Advanced Prostate Cancer
Sarkar, P. L. (2017) · Queensland University of Technology · doi:10.5204/thesis.eprints.110524
Physiopathology, Diagnosis, and Treatment of Secondary Female Hypogonadism
Antoniou-Tsigkos, A., Μacut, D., & Mastorakos, G. P. (2017) · Endocrinology · doi:10.1007/978-3-319-38681-2_9-1
Evaluation of Serum Testosterone Level in Men with Type 2 Diabetes Mellitus
Sangamesh, S. (2017) · Journal of Medical Science And clinical Research · doi:10.18535/jmscr/v5i11.192
“Hypogonadism develops due to reduced production of sex hormones such as testosterone and leads to diminished gonadal activity [3] .”
BackgroundMedical Management of Patients Before and After Bariatric Surgery
Arutchelvam, V. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-48559-3.00027-0
Hipogonadismo associado à obesidade: efeitos do tratamento com citrato de clomifeno
Soares, A. H. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2018.tde-13062018-074535 · Cited by 2
To Study Serum Testosterone Levels in Metabolic Syndrome
Wadhera, N., Bhatnagar, A., Gupta, A. K., Dubey, G., Chaudhary, S., & Sharma, S. (2019) · International Journal of Contemporary Medical Research [IJCMR] · doi:10.21276/ijcmr.2019.6.1.14
TRASTORNOS DE LA FERTILIDAD EN EL HOMBRE CON DIABETES TIPO 1 Y 21
Pomares, M. L., Burruchaga, A., Ávila, P., Ré, M., Constanzo, P., Suárez, S., Dionisi, D., Maraschio, M., Méndez, J., Muratore, C., et al. (2014) · Revista de la Sociedad Argentina de Diabetes · doi:10.47196/diab.v48i3.188
Obesity and Male Osteoporosis: Protective Factor?
Greco, E. A., Mocini, E., Marocco, C., Lenzi, A., & Migliaccio, S. (2020) · Trends in andrology and sexual medicine · doi:10.1007/978-3-319-96376-1_12
Maduka, I. C., & Nnamdi Ngozika, A. (2018) · International Journal of Research -GRANTHAALAYAH · doi:10.29121/granthaalayah.v6.i8.2018.1257
“Among these factors, an important role seems to be played by hyperglycaemia, insulin resistance and by some mediators of inflammation like interleukins and tumor necrosis factor (Dandona and Dhindsa, 2011).”
BackgroundUtilizing Temporal Information in The EHR for Developing a Novel Continuous Prediction Model
Hsieh, K. (2019) · Digital Commons-TMC (Texas Medical Center)
Makaya, T., Varughese, R., Ryan, F. J., & Pal, A. (2021) · Trends in andrology and sexual medicine · doi:10.1007/978-3-030-80015-4_5
Valencia, W. M., & Florez, H. J. (2021) · Springer eBooks · doi:10.1007/978-3-030-76271-1_20
Zhao, P. T., Su, D., & Seftel, A. D. (2014) · Springer eBooks · doi:10.1007/978-1-4614-9047-0_24
Dhindsa, S. (2022) · Wiley eBooks · doi:10.1002/9781119484288.ch85
Self-citationMaggio, M. G., Lauretani, F., & Ceda, G. P. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780198701590.003.0149
Maiorino, M. I., Bellastella, G., & Esposito, K. (2019) · Endocrinology · doi:10.1007/978-3-319-27316-7_16-2
Batista, P. A. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2022.tde-23062022-103929
Chuang, S., Ngu, K.-Y., Lee, C., Chien, M.-N., Huang, Y.-C., Shih, H., & Liu, S.-C. (2022) · Archives of Medical Science · doi:10.5114/aoms/152175
“suggested that obesity can also lead to androgen deficiency in men with T2D by enhancing 15 aromatase activity.(40) 16”
BackgroundReproductive Disorders and Obesity in Males and Females and Focus on the Polycystic Ovary Syndrome
Repaci, A., & Pasquali, R. (2016) · Springer eBooks · doi:10.1007/978-3-319-11251-0_40
“A recent systematic review assessed the metabolic effects of testosterone replacement therapy on hypotestosteronemic men with T2DM and found that this treatment improved glycemic control and decreased triglyceride levels in most of these patients (Dandona and Dhindsa 2011; Allan 2014).”
BackgroundHypogonadismus, Infertilität und sexuelle Dysfunktion bei systemischen Erkrankungen
Sartorius, G. A., & Handelsman, D. J. (2021) · Springer Reference Medizin · doi:10.1007/978-3-662-61904-9_34-1 · Cited by 1
Hypogonadismus, Infertilität und sexuelle Dysfunktion bei systemischen Erkrankungen
Sartorius, G. A., & Handelsman, D. J. (2023) · Springer Reference Medizin · doi:10.1007/978-3-662-61901-8_34 · Cited by 1
Shakya, S. (2022) · Chula Digiverse · doi:10.58837/chula.the.2022.320 · Cited by 3
Incidence, temporal trends, and socioeconomic aspects of male hypogonadismPreprint
Percik, R., Vered, S., & Liel, Y. (2023) · Research Square · doi:10.21203/rs.3.rs-3677985/v1
Düğer, H. (2024) · Journal of Health Sciences and Medicine · doi:10.32322/jhsm.1387621 · Cited by 1
The Impact of Male Obesity on Sex Hormones
Moreira, E. C. N. D. G., Machado, D. A. J. F., Delfino, B. A., Matos, G. O. A., & Zaccarelli-Marino, M. A. (2023) · Journal of Obesity and Weight-loss Medication · doi:10.23937/2572-4010.1510048 · Cited by 1
Shafiepour, M., shamsinejad, S., Karimifard, M., & Ahmadinia, H. (2024) · مجله علمی دانشگاه علوم پزشکی رفسنجان · doi:10.61186/jrums.22.11.1179
Metabolik sendrom ve erkek cinsel işlevi bozukluğu
Ateş, A., Özsoy, Ç., & Tuzcu, A. (2024) · Androloji Bülteni · doi:10.24898/tandro.2024.95815
“[38] Çalışmalarda pre-diyabetik durumun bile ED riskini ar-tırabileceğini gösterilmilştir.”
GLP‐1 receptor agonists versus testosterone in male reproductive health: A critical perspective
Torres, J. O., Lima, M. G., Bouça, B., & Silva-Nunes, J. (2025) · Diabetes, obesity and metabolism · doi:10.1111/dom.16404 · Cited by 1
“2,3,8 This trial compared semaglutide and testosterone replacement therapy (TRT) for their effects on functional hypogonadism and semen quality in men with T2D.”
Il peso di essere padre: quando il girovita mette KO la fertilità maschile
Valentina, L. D., Conte, I., Spaggiari, G., Rochira, V., & Santi, D. (2025) · L Endocrinologo · doi:10.1007/s40619-025-01624-x
“Infatti, diversi studi condotti in questo ambito hanno di-mostrato come l’ipogonadismo si associ all’aumentata adi-posità addominale viscerale, alla resistenza insulinica e alla sindrome metabolica, mostrando una proporzionalità inver-sa tra il BMI e le concentrazioni di testosterone sierico [10].”
Hypogonadism in Men with Obesity and Type 2 Diabetes
Dhindsa, S., Ghanim, H., & Dandona, P. (2025) · Springer eBooks · doi:10.1007/978-3-031-89650-7_18
Self-citationAdeleye, J. O., Onasanya, A., Sonuga, O. O., Esan, A., & Adebiyi, A. A. (2025) · PubMed Central
Wh, K., Kamaruddin, N. A., & Sukor, N. (2025) · Journal of the ASEAN Federation of Endocrine Societies · doi:10.15605/jafes.040.02.11
Metadata
- Authors
- Dandona, P., & Dhindsa, S.
- Affiliations
- Kaleida Health (US)
- Corresponding author
- Dandona, Paresh
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2011-09-01
- Volume
- 96
- Issue
- 9
- Pages
- 2643-2651
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC3167667
- OpenAlex
- W2111728603
- Semantic Scholar
- fecffda5a7c16c9bb49b9b21398e4d0afefbc568
- Cited by
- 313
- References
- 75
- Citations by year
- 2026: 15 · 2025: 15 · 2024: 16 · 2023: 22 · 2022: 18 · 2021: 24 · 2020: 14 · 2019: 19 · 2018: 29 · 2017: 19 · 2016: 16 · 2015: 27 · 2014: 24 · 2013: 36 · 2012: 17
- FWCI
- 3.53
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01dk069805-04)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK069805, R01DK075877)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- hypogonadotropic hypogonadism, type 2 diabetes, obesity, androgen deficiency, free testosterone, luteinizing hormone, follicle-stimulating hormone, testosterone replacement therapy, insulin sensitivity, cardiovascular risk, C-reactive protein, anemia, sexual function, erectile dysfunction, phosphodiesterase inhibitors, waist circumference
- MeSH terms
- Diabetes Mellitus, Type 2, Humans, Hypogonadism, Male, Obesity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.